Incyte Corp
(STU:ICY)
€
100.3
-0.15 (-0.15%)
Market Cap: 20.19 Bil
Enterprise Value: 16.70 Bil
PE Ratio: 16.25
PB Ratio: 4.09
GF Score: 87/100 Incyte Corp at RBC Capital Markets Healthcare Conference Transcript
May 21, 2019 / 02:30PM GMT
Release Date Price:
€69.62
(+1.75%)
Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst
We're really pleased to have our next presenting company here, Incyte, represented by their President and CEO, Hervé Hoppenot. Hervé?
HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO
© -
Thank you. Thank you for inviting us.
Brian Corey Abrahams
RBC Capital Markets, LLC, Research Division - Senior Analyst
Thank you so much. Really appreciate it. A lot to cover. So yes, just -- let's get started.
Questions & Answers
Brian Corey Abrahams;HervÃ;Hoppenot
RBC Capital Markets, LLC, Research Division - Senior Analyst;
Maybe kicking off with GVHD since that's the next potential data point and catalyst that we're going to hear about. Can you -- maybe you could tell us a little bit more in terms of background on the GVHD program. And in particular, the Jakafi PDUFA date is coming up very soon push back to...
©
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot